The (R,R)-enantiomer of trans-indeno(1,2-b)-1,4-oxazines, process for its preparation and pharmaceutical formulation containing it
申请人:Merck & Co., Inc.
公开号:EP0080117B1
公开(公告)日:1987-12-02
US4431647A
申请人:——
公开号:US4431647A
公开(公告)日:1984-02-14
Method of use of enantiomers of trans-indeno[1,2-b]-1,4-oxazines
申请人:Merck & Co., Inc.
公开号:US04431647A1
公开(公告)日:1984-02-14
The (R,R)-enantiomers of trans-indeno[1,2-b]-1,4-oxazines demonstrate dopaminergic activity, whereas the (S,S)-enantiomers demonstrate .alpha.-adrenergic antagonist activity. They are prepared by cyclization of the appropriate chiral 2-amino-1-hydroxyindane.